330 related articles for article (PubMed ID: 16965549)
1. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Blain JF; Aumont N; Théroux L; Dea D; Poirier J
Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
[TBL] [Abstract][Full Text] [Related]
2. Roles for lipoprotein lipase in Alzheimer's disease: an association study.
Baum L; Wiebusch H; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):291-6. PubMed ID: 10936883
[TBL] [Abstract][Full Text] [Related]
3. The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease.
Scacchi R; Gambina G; Broggio E; Moretto G; Ruggeri M; Corbo RM
Neurosci Lett; 2004 Sep; 367(2):177-80. PubMed ID: 15331147
[TBL] [Abstract][Full Text] [Related]
4. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
[TBL] [Abstract][Full Text] [Related]
5. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
Culpan D; Cram D; Chalmers K; Cornish A; Palmer L; Palmer J; Hughes A; Passmore P; Craig D; Wilcock GK; Kehoe PG; Love S
Neurobiol Aging; 2009 Jul; 30(7):1052-60. PubMed ID: 18069092
[TBL] [Abstract][Full Text] [Related]
6. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
Reynolds WF; Rhees J; Maciejewski D; Paladino T; Sieburg H; Maki RA; Masliah E
Exp Neurol; 1999 Jan; 155(1):31-41. PubMed ID: 9918702
[TBL] [Abstract][Full Text] [Related]
9. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
[TBL] [Abstract][Full Text] [Related]
10. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
11. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the clinical manifestations of Alzheimer disease pathology.
Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
[TBL] [Abstract][Full Text] [Related]
16. ApoE genotype accounts for the vast majority of AD risk and AD pathology.
Raber J; Huang Y; Ashford JW
Neurobiol Aging; 2004; 25(5):641-50. PubMed ID: 15172743
[TBL] [Abstract][Full Text] [Related]
17. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles.
Kazama H; Ruberu NN; Murayama S; Saito Y; Nakahara K; Kanemaru K; Nagura H; Arai T; Sawabe M; Yamanouchi H; Orimo H; Hosoi T
Dement Geriatr Cogn Disord; 2004; 18(2):145-50. PubMed ID: 15211069
[TBL] [Abstract][Full Text] [Related]
18. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
[TBL] [Abstract][Full Text] [Related]
20. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
